Assignee
UTC THERAPEUTICS SHANGHAI CO LTD
CN·4 granted patents·3 pending applications·0 citations·filing 2022–2023
Top patents by PatentIndex Score
7 records- 0164US11897966B2Mesothelin-targetting antibodies, chimeric antigen receptors, and uses thereofUTC THERAPEUTICS SHANGHAI CO LTD·Filed 2022·Granted Feb 13, 2024·0 cites·28 claims
- 0263US11767368B1Antigen-binding protein and use thereofUTC THERAPEUTICS SHANGHAI CO LTD·Filed 2022·Granted Sep 26, 2023·0 cites·28 claims
- 0362US11993659B2BCMA targetting antibodies, chimeric antigen receptors, and uses thereofUTC THERAPEUTICS SHANGHAI CO LTD·Filed 2022·Granted May 28, 2024·0 cites·27 claims
- 0462US2025381223A1Humanized anti-cd28 antibody and bispecific antibody thereof with anti-cd40 antibodyUTC THERAPEUTICS SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 0559US2025161358A1Modified immune effector cells and uses thereofUTC THERAPEUTICS SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 0655US11667723B2Lymphocytes-antigen presenting cells co-stimulators and uses thereofUTC THERAPEUTICS SHANGHAI CO LTD·Filed 2022·Granted Jun 6, 2023·0 cites·36 claims
- 0754US2025144213A1Circular rna and use thereofUTC THERAPEUTICS SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when UTC THERAPEUTICS SHANGHAI CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →